MED-EL Cochlear implants: state of the art and a glimpse into the future.
Cochlear implantation is an accepted treatment method for adults and children with severe to profound hearing loss. Confidence in technology has led to changes in individuals who can receive a cochlear implant and changes in expected benefit with a cochlear implant. This article describes the research and development activities at MED-EL, which make possible the implementation of new speech-coding strategies as well as the application of acoustic and electric stimulation via a combined speech processor in MED-EL devices. Research on benefits from bilateral cochlear implantation and electric-acoustic stimulation are also reviewed. Finally, the potential of drug delivery systems is considered as a way to improve cochlear implant outcomes, and results from preliminary evaluations of a hybrid cochlear implant system with drug delivery capabilities are reported.
Hochmair
Ingeborg
I
MED-EL, Fürstenweg 77a, Innsbruck, Austria. ingeborg.hochmair@medel.com
Nopp
Peter
P
Jolly
Claude
C
Schmidt
Marcus
M
Schösser
Hansjörg
H
Garnham
Carolyn
C
Anderson
Ilona
I
D000161:Acoustic Stimulation / Q000295:instrumentation*; D003054:Cochlear Implants / Q000639:trends*; D005544:Forecasting; D006312:Hearing Loss, Bilateral / Q000534:rehabilitation; D006319:Hearing Loss, Sensorineural / Q000534:rehabilitation*; D006801:Humans; D011474:Prosthesis Design